The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGEX THERAPEUTICS INC | COM | 00848H108 | 2,677,060 | 2,997,156 | SH | DFND | 1 | 2,997,156 | 0 | 0 | |
AXON ENTERPRISE INC | COM | 05464C101 | 148,303,297 | 760,062 | SH | DFND | 1 | 760,062 | 0 | 0 | |
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 129,216,300 | 690,000 | SH | DFND | 1 | 690,000 | 0 | 0 | |
LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 49,259,034 | 34,935,485 | SH | DFND | 1 | 34,935,485 | 0 | 0 | |
MONSTER BEVERAGE CORP NEW | COM | 61174X109 | 534,937,341 | 9,312,976 | SH | DFND | 1 | 9,312,976 | 0 | 0 | |
ONCOCYTE CORP | COM | 68235C107 | 11,541,707 | 50,181,335 | SH | DFND | 1 | 50,181,335 | 0 | 0 | |
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 461,726,621 | 8,783,082 | SH | DFND | 1 | 8,783,082 | 0 | 0 |